Menarini opens new strategic headquarters in Dubai

Menarini, a leading Italian pharmaceutical group founded in 1886, has opened its regional headquarters in Dubai Science Park as part of its aim to expand its presence in the Middle East and Africa (MEA) region. Specialising in pharmaceutical research and manufacturing, consumer healthcare, oncology and diagnostics, the group is placing its new Menarini Middle East and Africa regional office in Dubai as it is an ideal hub to improve patient health and well-being in the region and form critical links with key industry players.

The opening ceremony was attended by influential healthcare personalities, including H.E. Dr. Amin Hussain Al Amiri, Assistant Deputy Minister of Health and Prevention in the UAE, Marwan Abdulaziz Janahi, Managing Director of Dubai Science Park, H.E. Nicola Lehner, UAE Ambassador. Nicola Lener, Italian Ambassador to the UAE, as well as high-level executives from Menarini’s global team, including Dr Luca Lastrucci, Group CEO, Dr Ugur Bingol, META President, and Dr Basel Thaher, Regional Head for the Middle East and General Manager for the MEA Region.

Luca Lastrucci, Menarini Group CEO, commented, “Today’s opening of our headquarters in Dubai is a significant milestone for our company as we expand our investment in the MEA region. Our presence in a leading pharmaceutical hub such as Dubai will strengthen Menarini’s capabilities and improve market access by delivering revolutionary products in cardiovascular, gastrointestinal and inflammatory diseases.” Lastrucci added: “The UAE government has shown unwavering support for investment in the pharma economy through its strong commercial infrastructure and impressive facilities. We see this as an important step in the right direction for Menarini and will continue to work side by side with the UAE government to improve healthcare standards and support the well-being of people in the UAE and beyond.”

Marwan Abdulaziz Janahi, managing director of Dubai Science Park, said: “We are committed to making Dubai a leading centre for science and healthcare in line with our leadership’s vision, creating an integrated ecosystem that fosters innovation and technological advancement. We are delighted to welcome a pharmaceutical giant such as Menarini Group to our vibrant community and provide them with the necessary support and framework to continue their expansion story as they enter the diverse MENA region. They will undoubtedly bring valuable knowledge and expertise to our ecosystem and help the city and the region achieve cutting edge results in pharmaceuticals and patient care.”  

Commenting on Menarini’s new regional launch, which is perfectly aligned with Dubai Industrial Strategy 2030, Dr Ali Al Sayed, Director of Pharmaceutical Services, Dubai Health Authority, said: “The defining aim of the Dubai 2030 strategy is to become a global hub for knowledge-intensive, sustainable and innovative businesses. As Menarini has long roots in medical research, it will make a significant contribution to this forward-looking strategy.  Together, we share Dubai’s overarching vision for healthcare, which is to position Dubai as a leading centre for healthcare knowledge, education and training.”

Menarini’s new regional headquarters in Dubai, with a presence in 140 countries and over 17,000 employees, will be guided by Menarini’s deeply rooted values: patient-centricity, person-centricity, commitment to quality, integrity and responsibility. This important milestone serves to confirm Menarini’s ongoing mission of treating disease on a global scale and prioritizing patient health above all else.

Elcin Barker Ergun, CEO of Menarini Group and member of the Board of Directors, concluded: “Today marks a historic moment for us as we open regional offices in Dubai to significantly expand our presence and portfolio in the Middle East. As a 135-year-old family-owned company, we look forward to serving even more patients in the Middle East in the coming years through our unwavering commitment to quality.

Follow our Telegram Chanel